期刊名称:JOURNAL OF THORACIC DISEASE
期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal

Journal of Thoracic Disease
The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, indexed in Pubmed/Pubmed Central in Dec 2011, and Science Citation Index Expanded (SCIE) in Feb 4, 2013. It is published quarterly (Dec 2009- Dec 2011) and bimonthly (Jan 2012- ), and openly distributed worldwide. JTD publishes manuscripts that describe new findings in the field, providing current, practical information on the diagnosis and treatment of conditions related to thoracic disease (lung disease, cardiology, esophagus, and breast disease). Original articles are considered most important and will be processed for rapid review by the members of Editorial Board. Clinical trial notes, Cancer genetics reports, Epidemiology notes and Technical notes are also published. Case reports implying new findings that have significant clinical impact are carefully processed for possible publication. All the submission and reviewing are conducted electronically so that rapid review is assured.
The Official Publication of:
- Guangzhou Institute of Respiratory Disease (GIRD)
- China State Key Laboratory of Respiratory Disease
- The First Affiliated Hospital of Guangzhou Medical College
- Society for Thoracic Disease (STD)
Endorsed by International COPD Coalition (ICC)
Indexing
Journal of Thoracic Disease has now been indexed/archived in
刊物介绍
Journal of Thoracic Disease (《胸部疾病杂志》;简称JTD;pISSN: 2072-1439;eISSN: 2077-6624;季刊;www.jthoracdis.com),广州呼吸疾病研究所和广州国家呼吸疾病重点实验室的官方出版物,于2009年12月正式创刊并出版第一期。2013年2月4日,被SCIE(即SCI)收录。
JTD属于原创的英文版杂志,每季度出版一期,稿源来自国内外同行的英文论文,其中国外的稿件占70%以上,并采用国内外同行专家评议(Peer-review)制度,采用与Lancet相同的Editorial Manage System在线投稿与审稿系统。
广州呼吸疾病研究所所长、呼吸疾病国家重点实验室主任钟南山院士担任总编辑,广州医学院第一附属医院院长何建行教授和广州呼吸疾病研究所副所长陈荣昌教授担任执行副总编辑。设数个专题编委组,分别为胸外科组、呼吸内科组、放疗组、肿瘤内科组、统计学组、医学论文写作栏目组。其栏目包括专家述评、论著、综述、病例讨论、医学继续教育等。刊登胸部疾病预防、诊断与治疗等最新研究进展,以肺癌的基础与临床转化研究(translational research)内容为报道重点。读者为从事胸部疾病诊疗的医生与研究人员,如胸外科、呼吸内科、肿瘤内科、放疗科和影像科等专业人员。
JTD的影响因子将于2014年6月最后一周由汤森路透(Thomson Reuters)正式公布。
Instructions to Authors
Author-instructions.pdf
Editorial Board
Editor-in-Chief: Prof. Dr. Zhong Nanshan, MD
Dr Prof Nanshan Zhong, MD (Edin), FRCS (Edin), FRCP (London), FRCP (Ireland), is a Medical Professor of Guangzhou Medical College, and a supervisor of respiratory medicine doctoral candidates. He was former President of Chinese Medical Association (2005-2009).He was named as ‘leader of clinical research in China’ by the Lancet.
He graduated from Beijing Medical College, majoring in medical sciences. From 1979 to 1981, Dr Zhong worked as a research associated at the Department of Respiratory Medicine, Royal Infirmary, University of Edinburgh and St. Bartholomew’s Hospital, University of London. He was the President of Chinese Thoracic Society (2000-2007), Former President of Chinese Medical Association (2005-2009). At present, he is the Director of Guangzhou Institute of Respiratory Diseases, and Director-general of China State Key Laboratory of Respiratory Diseases. In addition, he is an Academician of Chinese Academy of Engineering since 1996, which is the highest academic position in the field of Medicine in China.
Over the past decades, Prof Zhong has been a leader scientist in promoting China’s respiratory medicine towards the forefront of international advances. Prof Zhong was a Member of Executive Committee of GINA (Global Initiative of Asthma) during 1993-1995, Member of the Executive Committee of Asia-Pacific Society of Respiratory (1999-2005), International Reagent of American College of Chest Physicians in China (1999-2009), and now a Member of Executive Committee of the Global Alliance of Respiratory Diseases (GARD, since 2006).
He first developed and refined the definition of asymptomatic asthma, later cited by WHO, through his originally designed “simple bronchial provocation test" and epidemiological surveys. In a systemic review of etiology of chronic cough in China, he elucidated the neuroinflammatory mechanisms to gastroesophageal reflux induced cough. His methods for in-exercise diaphragmatic function assessment for the first time revealed the presence of protein-energy malnutrition in even 60% of patients with early to middle stage COPD, which generated a correction equation of basic energy intake in this cohort. A national epidemiological study steered by him showed the unprecedented prevalence of COPD in China. His famous research found that hydrosulfuryl-containing expectorants (carbocysteine) can be effective in preventing or reducing acute exacerbation of COPD. He has organized and participated in the development of a number of Chinese guidelines for diagnosis and management of bronchial asthma, COPD, chronic cough, SARS, and high-pathogenic avian flu. He was the first person describing SARS coronovirus as the main pathogen in 2003 SARS pandemic in Guangdong. As a leader in the management of 2002/2003 SARS outbreak in China, he successfully led his team in rescue, achieving lowest mortality of SARS infection (3.8% in Guangdong) among the world by rationale use of corticosteroid and non-invasive ventilation. He successfully developed a new vaccine using small molecule interference RNA technique in the prevention and treatment of SARS in Rhesus macaque. He led in writing a handbook which was later used by the WHO as a blueprint in developing a global response to this disease.
Professor Zhong is also a leader and principal investigator to more than 10 major scientific projects, including the State-973, State-863, Tenth State Five-year Plan, National Nature Science Grants, and WHO/GOLD global network. He has published a great number of papers in worldwide reputed SCI journals, including those in Nature Medicine, Lancet, BMJ, Am J Respir Crit Care Med, and more than 200 papers in State-level journals. His publications have received 438 citations. In 2008, one of his papers published in the Lancet was elected as “paper of the year”. Besides, he has published 16 books including Respiratory Medicine (National College Textbooks for Medical Postgraduates), Internal Medicine (National textbooks), Asthma: from Basic to Clinical, and has gained 9 technical patents.
Due to his great achievements in medical practices and scientific education, Prof Zhong was also a recipient to Second and Third Prizes for National Natural Sciences, Outstanding Contribution Award, First Prize of Guangdong Science and Technology Awards, and Bethune Medal (2004). He became National May Day Labor Medalist (2003), National Moral Models (2007), European Respiratory Society Lifetime Honorary Fellow (2008), People Who Moved China 2009, Advanced Individual of National Medical Health Care System (2009),Fifth Higher School Teaching Masters Award (2009) and National Award for Achievements in Teaching (2009).
Editorial Team
Executive Editor-in-Chief
Executive Editor-in-Chief (Cardiovascular Surgery)
Editorial Co-Directors & Executive Editors
Section Editor (Systematic Review and Meta-analysis)
|